Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS

Angers, FR

CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS Patent applications
Patent application numberTitlePublished
20120010824Non-Invasive Method for Assessing Liver Fibrosis Progression - The present invention relates to a non-invasive method for assessing liver fibrosis progression in an individual, said method comprising the steps of calculating the ratio of fibrosis level to cause duration and to a non-invasive method for assessing liver fibrosis progression in an individual, said method comprising the steps of measuring, at two different times t01-12-2012
20110313276NON-INVASIVE IN VITRO METHOD FOR QUANTIFYING LIVER LESIONS - An in-vitro non-invasive method for quantifying the lesions of the liver of the patient with metabolic steatosis addressing a diagnostic target, i.e. fibrosis, steatosis and/or steato-hepatitis (NASH) and measuring at least one marker selected from the group consisting of biomarkers and possibly clinical markers and possibly scores, the biomarkers being selected from the group consisting of glycemia, AST (aspartate aminotransferase), ALT (alanine aminotransferase), AST/ALT, AST.ALT, ferritin, platelets, prothrombin index, hyaluronic acid, haemoglobin, triglycerides; the biomarker selected from weight, body mass index, sex and age, hip perimeter, abdominal perimeter and ratio thereof; the scores being selected from score of fibrosis, area of fibrosis, fractal dimension of fibrosis, score of steatosis, area of steatosis, fractal dimension of steatosis and combining the measures in a mathematical function combining the measures through a binary (or ordinal) logistic function or multiple linear regression including the markers in order to obtain an end value.12-22-2011
20110306849Diagnosis of Liver Fibrosis and Cirrhosis - This invention relates to method of diagnosing the presence and/or severity of a liver pathology and/or of monitoring the effectiveness of a curative treatment against a liver pathology in an individual, leading to a score, comprising the combination, of at least one blood test and of at least one data issued from a physical method of diagnosing liver fibrosis, said data being selected from the group consisting of medical imaging data and clinical measurements, said combination being performed through a mathematical function. This invention also relates to a method wherein the combination through a mathematical function, of at least one blood test and of at least one data issued from a physical method of diagnosing liver fibrosis, is performed at least twice and the at least two resulting scores are combined in an algorithm based on the diagnostic reliable intervals.12-15-2011